Molekule Group Stock Current Valuation
| MKULDelisted Stock | 2.25 0.15 7.14% |
Valuation analysis of Molekule Group helps investors to measure Molekule's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Molekule's price fluctuation is very steady at this time. Calculation of the real value of Molekule Group is based on 3 months time horizon. Increasing Molekule's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Molekule stock is determined by what a typical buyer is willing to pay for full or partial control of Molekule Group. Since Molekule is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Molekule Stock. However, Molekule's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.25 | Real 1.79 | Hype 2.25 | Naive 2.2 |
The intrinsic value of Molekule's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Molekule's stock price.
Estimating the potential upside or downside of Molekule Group helps investors to forecast how Molekule stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Molekule more accurately as focusing exclusively on Molekule's fundamentals will not take into account other important factors: Molekule Group Company Current Valuation Analysis
Molekule's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Molekule Current Valuation | 45.01 M |
Most of Molekule's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Molekule Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Molekule Group has a Current Valuation of 45.01 M. This is 99.38% lower than that of the Machinery sector and 88.22% lower than that of the Industrials industry. The current valuation for all United States stocks is 99.73% higher than that of the company.
Molekule Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molekule's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Molekule could also be used in its relative valuation, which is a method of valuing Molekule by comparing valuation metrics of similar companies.Molekule is currently under evaluation in current valuation category among its peers.
Molekule Fundamentals
| Return On Equity | -1.17 | |||
| Return On Asset | -0.25 | |||
| Profit Margin | (1.53) % | |||
| Operating Margin | (1.47) % | |||
| Current Valuation | 45.01 M | |||
| Shares Outstanding | 34.65 M | |||
| Shares Owned By Insiders | 33.02 % | |||
| Shares Owned By Institutions | 30.70 % | |||
| Number Of Shares Shorted | 775.6 K | |||
| Revenue | 48.03 M | |||
| Gross Profit | 277.62 K | |||
| EBITDA | 8.34 M | |||
| Net Income | (1.55 M) | |||
| Total Debt | 46.72 M | |||
| Book Value Per Share | 1.20 X | |||
| Cash Flow From Operations | (41.28 M) | |||
| Short Ratio | 0.78 X | |||
| Earnings Per Share | (0.68) X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 91 | |||
| Market Capitalization | 1.87 M | |||
| Total Asset | 52.32 M | |||
| Retained Earnings | (7.92 M) | |||
| Working Capital | 20.22 M | |||
| Z Score | 1.72 | |||
| Net Asset | 52.32 M |
About Molekule Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Molekule Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molekule using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molekule Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Molekule Stock
If you are still planning to invest in Molekule Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molekule's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |